M. Stahl (Berlin, Germany), S. Fustik (Skopje, North Macedonia)
Introduction
M. Stahl (Berlin, Germany), S. Fustik (Skopje, North Macedonia)
|  |
Volume of trapped gas in adolescents with cystic fibrosis starting CFTR modulator thera
M. Dumas (Toronto, Canada), R. Jensen (Toronto, Canada), M. Shaw (Toronto, Canada), A. West (Toronto, Canada), S. Munidasa (Toronto, Canada), B. Zanette (Toronto, Canada), J. Woods (Ohio, United States), P. Robinson (Sydney, Australia), G. Santyr (Toronto, Canada), F. Ratjen (Toronto, Canada)
|    |
Long-term benefits of early initiation of ivacaftor (IVA) in people with cystic fibrosis (CF): interim results from an ongoing registry-based study
M. Higgins (London, United Kingdom), N. Volkova (Boston, United States), T. Farietta (Boston, United States), M. Liu (Boston, United States), R. Wu (Bethesda , United States), A. Elbert (Bethesda , United States), S. Charman (London, United Kingdom), A. Lee (London, United Kingdom), S. Cunningham (Edinburgh, United Kingdom)
| |
Long-term effectiveness of dual CFTR modulator treatment of Cystic Fibrosis
D. Muilwijk (Utrecht, Netherlands), D. Zomer (Baarn, Netherlands), V. Gulmans (Baarn, Netherlands), R. Eijkemans (Utrecht, Netherlands), K. Van Der Ent (Utrecht, Netherlands)
| |
A multimodal MRI protocol for structure and functional lung, gut and liver imaging in cystic fibrosis (CF) for children aged 6 and above.
C. Ng (Nottingham (Nottinghamshire), United Kingdom), N. Palaniyappan (Nottingham (Nottinghamshire), United Kingdom), Z. Peggs (Nottingham (Nottinghamshire), United Kingdom), A. Yule (Nottingham (Nottinghamshire), United Kingdom), C. Bradley (Nottingham (Nottinghamshire), United Kingdom), N. Dellschaft (Nottingham (Nottinghamshire), United Kingdom), J. Brooke (Nottingham (Nottinghamshire), United Kingdom), L. Marciani (Nottingham (Nottinghamshire), United Kingdom), R. Spiller (Nottingham (Nottinghamshire), United Kingdom), G. Aithal (Nottingham (Nottinghamshire), United Kingdom), C. Hoad (Nottingham (Nottinghamshire), United Kingdom), S. Francis (Nottingham (Nottinghamshire), United Kingdom), P. Gowland (Nottingham (Nottinghamshire), United Kingdom), I. Hall (Nottingham (Nottinghamshire), United Kingdom), A. Prayle (Nottingham (Nottinghamshire), United Kingdom), A. Smth (Nottingham (Nottinghamshire), United Kingdom)
| |
Multivolume Magnetic Resonance Imaging (MRI) to assess response to triple-combination Elexacaftor/Tezacaftor/Ivacaftor (ETI) in the lung of patients with Cystic Fibrosis (CF)
F. Pennati (Milano (MI), Italy), I. Borzani (Milano (MI), Italy), E. Nazzari (Milano (MI), Italy), M. Russo (Milano (MI), Italy), G. Bischetti (Milano (MI), Italy), C. Rosazza (Milano (MI), Italy), C. Sciarrabba (Milano (MI), Italy), A. Mariani (Milano (MI), Italy), G. Carrafiello (Milano (MI), Italy), A. Aliverti (Milano (MI), Italy), C. Colombo (Milano (MI), Italy)
| |
Efficacy of elexacaftor/tezacaftor/ivacaftor therapy assessed by lung ultrasound
U. Krivec (Ljubljana, Slovenia), M. Praprotnik (Ljubljana, Slovenia), M. Aldeco (Ljubljana, Slovenia), D. Lepej (Ljubljana, Slovenia), A. Zver (Ljubljana, Slovenia), J. Rodman Berlot (Ljubljana, Slovenia), S. Šetina Šmid (Ljubljana, Slovenia), Š. Dolenc (Ljubljana, Slovenia), J. Lozar Krivec (Ljubljana, Slovenia)
| |
Breath profiles in cystic fibrosis children treated with CFTR modulators
E. Seidl (Toronto, Canada), J. Licht (Toronto, Canada), G. Slingers (Leiden, Netherlands), R. De Vries (Leiden, Netherlands), F. Ratjen (Toronto, Canada), H. Grasemann (Toronto, Canada)
| |
Elexacaftor-tezacaftor-ivacaftor (ETI) treatment improves Lung Clearance Index (LCI) in patients with Cystic Fibrosis (CF) independently from baseline respiratory function
F. Lucca (Verona, Italy), S. Volpi (Verona, Italy), R. Guarise (Verona, Italy), A. Borruso (Verona, Italy), M. Signorini (Verona, Italy), M. Cipolli (Verona, Italy)
| |
Effect of ELX/TEZ/IVA treatment on lung ventilation in children with cystic fibrosis – comprehensive assessment using spirometry, MBW, structural and functional lung MRI
C. Streibel (Bern, Switzerland), C. Willers (Bern, Switzerland), O. Pusterla (Basel, Switzerland), G. Bauman (Basel, Switzerland), O. Bieri (Basel, Switzerland), E. Stranzinger (Bern, Switzerland), B. Brabandt (Bern, Switzerland), P. Latzin (Bern, Switzerland), E. Kieninger (Bern, Switzerland)
| |
Late Breaking Abstract - A multimodal cell atlas of the pediatric lower airway
S. Shanthikumar (Parkville, Australia), J. Maksimovic (Parkville, Australia), A. Oshlack (Parkville, Australia), S. Ranganathan (Parkville, Australia), M. Neeland (Parkville, Australia)
| |
Discussion
| |